Innate Regulation of Adaptive Immunity

描述（由申请人提供）：生产可以中和靶病原体的强效高亲和力抗体仍然是疫苗研究的中心目标。虽然我们对抗体分子本身了解很多，但对产生抗体的高亲和力记忆B细胞的编程仍然知之甚少。许多有前途的疫苗抗原不能使用当代疫苗制剂引发保护性抗体。因此，在我们对抗体亲和力成熟的基本理解以及如何使用合理的蛋白质疫苗接种来增强不良免疫原性方面仍然存在主要差距。 研究重点：使用蛋白质疫苗制剂需要佐剂来诱导有效的抗体反应。滤泡辅助性T（TFH）细胞是一类新的免疫调节细胞，专门控制记忆B细胞发育的多个阶段。在这里，我们研究了抗原特异性TFH发展的先天性细胞和分子调节因子在初始引发点和疫苗加强后。 具体目标：使用新的单细胞策略，我们将剖析肽MHCII表达树突状细胞（DC）内控制抗原特异性TFH编程在体内（SA-1）的调节程序的分子组成部分。在抗原回忆后，我们发现记忆B细胞形成二次GC反应，使其表达的BCR重新多样化，并有持续克隆选择的证据。重要的是，在疫苗加强时添加二级佐剂增强了记忆B细胞应答内的亲和力成熟。这些最近的发现改变了BCR亲和力成熟的流行观点，并表明了调节高亲和力B细胞记忆（SA-2）的新的先天机制。 影响：我们使用蛋白质疫苗接种的多克隆小鼠模型，以及最先进的抗原特异性免疫功能的单细胞分析。这些模型抗原的高分辨率研究有能力改变围绕现有疫苗范式的基本概念框架。重要的是，这些基本的新原理和测定法可用于重新设计当代疫苗制剂，以优化对更复杂抗原的高亲和力B细胞免疫。

DESCRIPTION (provided by applicant): Producing potent high-affinity antibodies that can neutralize target pathogens remains a central goal for vaccine research. While a great deal is known about antibody molecules themselves, still too little is understood about the programming of high-affinity memory B cells that produce them. Many promising vaccine antigens fail to elicit protective antibodies using contemporary vaccine formulations. Thus, major gaps remain in our basic understanding of antibody affinity maturation and how to enhance poor immunogenicity using rational protein vaccination. Research Focus: Adjuvants are required to induce potent antibody responses using protein-based vaccine formulations. Follicular helper T (TFH) cells are a new class of immune regulator specialized to control multiple stages of memory B cell development. Here, we examine the innate cellular and molecular regulators of antigen-specific TFH development at the point of initial priming and following the vaccine boost. Specific Aims: Using new single cell strategies, we will dissect the molecular components of regulatory programs within peptide MHCII-expressing dendritic cell (DC) that control antigen-specific TFH programming in vivo (SA-1). Upon antigen recall, we now reveal that memory B cells form secondary GC reactions, re-diversify their expressed BCR, with evidence for ongoing clonal selection. Importantly, addition of secondary adjuvant at the vaccine boost enhanced affinity maturation within the memory B cell response. These recent findings alter the prevailing view of BCR affinity maturation and indicate new innate mechanisms for regulating high-affinity B cell memory (SA-2). Impact: We use polyclonal murine models of protein vaccination with state-of-the-art single cell analyses of antigen-specific immune function. These high-resolution studies of model antigens have the capacity to shift the basic conceptual framework that surrounds existing vaccine paradigms. Importantly, these basic new principles and assays can be used to re-design contemporary vaccine formulations that optimize high-affinity B cell immunity to more complex antigens.